$AZN Cashflow Statement | Understand Stock

$AZN

$172.06 +$0.57 (0.33%) Close

$AZN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Profit before tax
Finance income and expense
Share of after tax losses in associates and joint ventures
Depreciation, amortisation and impairment
Increase in trade and other receivables
Increase in inventories
Increase in trade and other payables and provisions
Gains on disposal of intangible assets
Gains on disposal of investments in associates and joint ventures
Fair value movements on contingent consideration arising from business combinations
Non-cash and other movements
Cash generated from operations
Interest paid
Tax paid
Net cash inflow from operating activities

Cash flows from investing activities
Acquisition of subsidiaries, net of cash acquired
Payments upon vesting of employee share awards attributable to business combinations
Payment of contingent consideration from business combinations
Purchase of property, plant and equipment
Disposal of property, plant and equipment
Purchase of intangible assets
Disposal of intangible assets and assets held for sale
Disposal of intangible assets
Movement in profit-participation liability
Purchase of non-current asset investments
Disposal of non-current asset investments
Movement in short-term investments, fixed deposits and other investing instruments
Payments to associates and joint ventures
Disposal of investments in associates and joint ventures
Interest received
Net cash outflow from investing activities
Net cash inflow before financing activities

Cash flows from financing activities
Proceeds from issue of share capital
Own shares purchased by Employee Benefit Trusts
Payments to acquire non-controlling interests
Issue of loans and borrowings
Repayment of loans and borrowings
Dividends paid
Hedge contracts relating to dividend payments
Repayment of obligations under leases
Movement in short-term borrowings
Payment of Acerta Pharma share purchase liability
Net cash outflow from financing activities
Net increase/(decrease) in Cash and cash equivalents in the period
Cash and cash equivalents at the beginning of the period
Exchange rate effects
Cash and cash equivalents at the end of the period
Cash and cash equivalents

Comments